Cholinesterase inhibitors for Parkinson’s disease-related visual hallucinations unresponsive to atypical antipsychotics
Journal Title: Archives of Medical Science - Year 2007, Vol 3, Issue 1
Abstract
Introduction: Considering lack of accepted guideline in cases of Parkinson’s disease-related visual hallucinations with poor response or intolerance to antipsychotics, and their possible cholinergic pathogenesis, the trial with cholinesterase inhibitors seems to be legitimated. Material and methods: Five patients with PD (with or without dementia) complicated by VH and unresponsive to atypical antipsychotics were offered a 12-week, open-label trial of a cholinesterase inhibitor. Results: All 5 subjects completed the trial with no major adverse effects and, noteworthy, no discontinuations due to adverse events. VH resolved in 4 subjects and were markedly diminished in one person. Neither changes in UPDRS scores nor exaggeration of subjective complaints about extrapyramidal symptoms were noted during treatment. Conclusions: Cholinesterase inhibitors, rivastigmine or donepezil, might represent a useful alternative to antipsychotics for patients with PD accompanied by VH even in the absence of dementia.
Authors and Affiliations
Tomasz Sobow
Keywords
Related Articles
- EP ID EP154668
- DOI -
- Views 155
- Downloads 0
Association of glutathione-S-transferase P1 genotypes with susceptibility to bronchial asthma in children
Introduction: Asthma is characterized by airway inflammation, a critical component of which is oxidative stress. We describe an association study designed to examine whether allelic variation at the glutathione-S-transfe...
The prevalence of obesity of children (aged 13-15) and the significance of selected obesity risk factors
Dynamics of changes of the BNP concentration in patients with stable angina pectoris qualified for PTCA. Dependence on the selected morphological and haemodynamic parameters
Introduction: Cardiomyocytes of human heart ventricles synthesize and generate BNP. The effect of BNP on the volume of the vascular bed contributes significantly to successful arterial pressure control. The usefulness of...
Toxic epidermal necrolysis (Lyell’s syndrome): case report and review of the literature
Rhabdomyolysis following severe hypokalemia caused by Conn’s syndrome
Rhabdomyolysis denotes a clinical and laboratory syndrome that results from a rapid breakdown of skeletal muscle cells. This releases potentially toxic muscle cell components into the circulation which may cause life-t...